Loading Results
We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.
Find University Hospitals Doctors
Amy Armstrong, MD

Amy Armstrong, MD

  • Residency Program Director, Obstetrics and Gynecology, UH Cleveland Medical Center
  • Clinical Instructor, CWRU School of Medicine
  • Assistant Professor, CWRU School of Medicine
  • Specialty: OB/GYN-Gynecologic Oncology, OB/GYN-General
  • Location:
    UH Seidman Cancer Center
    11100 Euclid Ave
    Cleveland, OH 44106

Biography: Amy Armstrong, MD

Certifications & Memberships

  • Gynecologic Oncology - American Board of Obstetrics and Gynecology
  • Obstetrics and Gynecology - American Board of Obstetrics and Gynecology


Fellowship | Gynecologic Oncology
Gynecologic Oncology - Uh Case Medical Center (2014 - 2017)

Fellowship | Female Pelvic Surgery
Female Pelvic Surgery - Uh Case Medical Center (2013 - 2014)

Residency | Obstetrics and Gynecology
Obstetrics and Gynecology - Uh Case Medical Center (2009 - 2013)

Medical Education
University Of Cincinnati College Of Medicine (2009)

The Ohio State University (2005)


Amy Armstrong, MD, joined the Division of Gynecologic Oncology in 2017. She completed both her residency and Gynecologic Oncology Fellowship at University Hospitals Cleveland Medical Center. She is a member of the NRG Endometrial Cancer Committee. NRG Oncology is one of the five U.S. network groups of the NCI National Clinical Trials Network (NCTN) Program. She also serves as coordinator for the Department of Obstetrics & Gynecology Grand rounds and is actively involved in implementing a Health Science Systems Curriculum for the Ob/Gyn residents during their gynecologic oncology rotations.

Research Publications

PubMed Publications

Featured Videos

Watch to find out more about this University Hospitals provider.

Industry Relationships

University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.

UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.

View UH’s policy (PDF) on practitioner-industry relationships.

As of December 31, 2016, Amy Armstrong did not disclose any Outside Relationships with Industry.